rs786205084
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The ENST00000410020.8(DYSF):c.5546G>A(p.Arg1849Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,459,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
ENST00000410020.8 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYSF | NM_001130987.2 | c.5546G>A | p.Arg1849Lys | missense_variant, splice_region_variant | 49/56 | ENST00000410020.8 | NP_001124459.1 | |
DYSF | NM_003494.4 | c.5429G>A | p.Arg1810Lys | missense_variant, splice_region_variant | 48/55 | ENST00000258104.8 | NP_003485.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYSF | ENST00000410020.8 | c.5546G>A | p.Arg1849Lys | missense_variant, splice_region_variant | 49/56 | 1 | NM_001130987.2 | ENSP00000386881 | A1 | |
DYSF | ENST00000258104.8 | c.5429G>A | p.Arg1810Lys | missense_variant, splice_region_variant | 48/55 | 1 | NM_003494.4 | ENSP00000258104 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459764Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726092
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2B Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 27, 2013 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2010 | - - |
Likely pathogenic, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Dec 03, 2018 | The homozygous p.Arg1849Lys variant in DYSF (sometimes called p.Gly1802ValfsX17 due to its splicing effect) was identified by our study in one individual with limb-girdle muscular dystrophy (LGMD) (LGMD). This variant was absent from large population studies. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The p.Arg1849Lys variant in DYSF has been reported in 7 Portuguese individuals with LGMD, including one individual compound heterozygous with this variant and a second variant not reported in ClinVar, c.5657delG (PMID: 20535123). In vitro functional studies with peripheral blood and muscle tissue from 7 unrelated individuals with LGMD and this variant (6 homozygous, 1 heterozygous) provide some evidence that the p.Arg1849Lys variant may impact protein function. Transcript analysis demonstrated an abnormal lack of splicing Exon 49, resulting in a reading frameshift and early termination of the protein (PMID: 20535123). However, these types of assays may not accurately represent biological function. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PS3, PP3 (Richards 2015). - |
Distal myopathy with anterior tibial onset;C1850889:Autosomal recessive limb-girdle muscular dystrophy type 2B;C4551973:Miyoshi muscular dystrophy 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 19, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 09, 2016 | - - |
Qualitative or quantitative defects of dysferlin Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 22, 2023 | This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 1810 of the DYSF protein (p.Arg1810Lys). RNA analysis indicates that this missense change induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of limb-girdle muscular dystrophy (PMID: 20535123; Invitae). This variant is also known as c.5492G>A and c.5525G>A. ClinVar contains an entry for this variant (Variation ID: 18443). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this missense change results in skipping of exon 49 and introduces a premature termination codon (PMID: 20535123). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at